LOWELL, Mass., Oct. 11, 2016 -- Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, is pleased to announce the addition of Ed Ognibene as Vice President of Product Development. Ed will report directly to the CEO, Robert Spignesi.
Mr. Ognibene brings over 20 years of technology and product development experience with sophisticated scientific instrumentation. Most recently, he held the position of Director of Engineering / Systems Development at Waters Corporation in the Separation Systems division, where he successfully managed the R&D and Engineering teams from the acquisition of Thar Instruments, Inc., as well as the integration of these groups into the broader corporate development organization. Concurrently, Mr. Ognibene oversaw a major development program to replace a product line with innovative new systems. Prior to this, he was responsible for driving the development of novel industry leading chromatographic platform systems. Before Waters, Mr. Ognibene worked at SatCon Technologies, a MIT start-up, where he managed the Mechanical Engineering Group and was also responsible for Program Management and technology/business development.
“I am thrilled to welcome an executive of Ed’s caliber and experience to our team,” said CEO Robert Spignesi. “His track record of leading innovative technology, product development programs, and organizations will be instrumental to our continued growth and success.”
“I am pleased to step into the VP of Product Development role and take on this assignment during an exciting phase of the company’s growth,” said Mr. Ognibene. “I look forward to ensuring that our customers experience the most innovative products as they implement Rapid Micro Biosystems’ technologies throughout their organizations.”
Ed holds a PhD and MS in Mechanical Engineering from MIT and a BSME from SUNY Stony Brook. Ed is a member of ASME, Tau Beta Pi, and Sigma Xi honor societies.
About Rapid Micro Biosystems
Rapid Micro Biosystems delivers the Growth Direct™ System, an automated, non-destructive rapid detection and enumeration technology based on the compendial method for microbial quality control in pharmaceutical manufacturing. The system automates and accelerates detection and enumeration in the areas of sterility testing, environmental monitoring, and bioburden testing, eliminating manual steps and analysis. The detection technology uses the natural auto-fluorescence of microbes and requires no reagents. For more information about Rapid Micro Biosystems visit www.rapidmicrobio.com
Contact: Eugenia Kendrick Rapid Micro Biosystems [email protected]


Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 



